Daniela Cilloni

53PUBLICATIONS
224CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical virologyMedical biotechnology diagnostics (incl. biosensors)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Oct 08, 2026
Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) - A Trial in Progress.

|Jun 11, 2026
A dynamic prognostic model for polycythemia vera long-term outcomes in patients treated with ruxolitinib.

|Apr 06, 2026
Targeting BCL-xL in Myeloid Malignancies: From Inhibitors to PROTAC.

Daniela Cilloni, Alessandro Ferrando, Francesco Frassoni

|Mar 14, 2026
Clonal Dynamics of FLT3-ITD from Diagnosis to Relapse: Ultra-Sensitive Patient-Specific Monitoring by ddPCR.

Alessandro Ferrando, Johanna Umurungi, Alice Costanza Danzero

|Mar 05, 2026
Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosis.

Barbara Mora, Francesca Palandri, Paola Guglielmelli

|Feb 13, 2026
Ultra-Sensitive Mutation Detection Technology in Myeloid Neoplasms: New Tools for Patient Monitoring.

Alessandro Ferrando, Valentina Bonuomo, Arianna Savi

Pageof 9

Frequent Collaborators

17 joint publications

Jessica Petiti

11 joint publications

Massimo Breccia

7 joint publications

Barbara Pergolizzi

7 joint publications

Enrico Bracco